搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodoferax ferrireducens Non-canonical purine NTP pyrophosphatase (Rfer_1630) CSB-YP632526RAAJ
CSB-EP632526RAAJ
CSB-BP632526RAAJ
CSB-MP632526RAAJ
CSB-EP632526RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP632527RAAJ1
CSB-EP632527RAAJ1
CSB-BP632527RAAJ1
CSB-MP632527RAAJ1
CSB-EP632527RAAJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP632528RAAJ
CSB-EP632528RAAJ
CSB-BP632528RAAJ
CSB-MP632528RAAJ
CSB-EP632528RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens 50S ribosomal protein L19 (rplS) CSB-YP632529RAAJ
CSB-EP632529RAAJ
CSB-BP632529RAAJ
CSB-MP632529RAAJ
CSB-EP632529RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP632530RAAJ
CSB-EP632530RAAJ
CSB-BP632530RAAJ
CSB-MP632530RAAJ
CSB-EP632530RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Protein-export protein SecB (secB) CSB-YP632531RAAJ
CSB-EP632531RAAJ
CSB-BP632531RAAJ
CSB-MP632531RAAJ
CSB-EP632531RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens GTPase obg (obg) CSB-YP632532RAAJ
CSB-EP632532RAAJ
CSB-BP632532RAAJ
CSB-MP632532RAAJ
CSB-EP632532RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens 60 kDa chaperonin 1 (groL1), partial CSB-YP632533RAAJ
CSB-EP632533RAAJ
CSB-BP632533RAAJ
CSB-MP632533RAAJ
CSB-EP632533RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable FAD synthase (R53.1), partial CSB-YP632534CXY
CSB-EP632534CXY
CSB-BP632534CXY
CSB-MP632534CXY
CSB-EP632534CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant rRNA 2'-O-methyltransferase fibrillarin (fib-1) CSB-YP632535CXY
CSB-EP632535CXY
CSB-BP632535CXY
CSB-MP632535CXY
CSB-EP632535CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA) CSB-YP632536RAAJ
CSB-EP632536RAAJ
CSB-BP632536RAAJ
CSB-MP632536RAAJ
CSB-EP632536RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens 7-cyano-7-deazaguanine synthase (queC) CSB-YP632537RAAJ
CSB-EP632537RAAJ
CSB-BP632537RAAJ
CSB-MP632537RAAJ
CSB-EP632537RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zinc finger C2HC domain-containing protein T03G11.3 (T03G11.3) CSB-YP632538CXY
CSB-EP632538CXY
CSB-BP632538CXY
CSB-MP632538CXY
CSB-EP632538CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Phosphatidylserine decarboxylase proenzyme (psd) CSB-YP632539RAAJ
CSB-EP632539RAAJ
CSB-BP632539RAAJ
CSB-MP632539RAAJ
CSB-EP632539RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Alanine racemase (alr) CSB-YP632540RAAJ
CSB-EP632540RAAJ
CSB-BP632540RAAJ
CSB-MP632540RAAJ
CSB-EP632540RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Transthyretin-like protein 46 (ttr-46) CSB-YP632541CXY
CSB-EP632541CXY
CSB-BP632541CXY
CSB-MP632541CXY
CSB-EP632541CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable ATP-dependent RNA helicase A (rha-1), partial CSB-YP632542CXY
CSB-EP632542CXY
CSB-BP632542CXY
CSB-MP632542CXY
CSB-EP632542CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens ATP synthase subunit b 1 (atpF1), partial CSB-YP632543RAAJ
CSB-EP632543RAAJ
CSB-BP632543RAAJ
CSB-MP632543RAAJ
CSB-EP632543RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodoferax ferrireducens Chaperone surA (surA) CSB-YP632544RAAJ
CSB-EP632544RAAJ
CSB-BP632544RAAJ
CSB-MP632544RAAJ
CSB-EP632544RAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caenorhabditis elegans Beta carbonic anhydrase 1 (bca-1) CSB-YP632545CXY
CSB-BP632545CXY
CSB-MP632545CXY
CSB-EP632545CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>